|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
146,000,000 |
Market
Cap: |
16.87(B) |
Last
Volume: |
1,904,666 |
Avg
Vol: |
1,333,207 |
52
Week Range: |
$92.79 - $212.65 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Electronics |
Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : 11.4 |
Insider 6 Months : 11.4 |
Insider 3/6 Months : 23.2 |
|
Guru Rank Number : 691 |
Guru Rank Value : 2.3 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co. provides whole-genome sequencing, genotyping, noninvasive prenatal testing (NIPT), and product support services. Using Co.'s services, customers can perform whole-genome sequencing projects and microarray projects (including large-scale genotyping studies and whole-genome association studies). Co. provides NIPT services through its partner laboratories that direct samples to Co. on a test send-out basis in its Clinical Laboratory Improvements Amendments-certified, College of Pathologists-accredited laboratory. Co. also provides support services to customers who have purchased its products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
7,330 |
7,330 |
7,330 |
7,330 |
Total Buy Value |
$991,672 |
$991,672 |
$991,672 |
$991,672 |
Total People Bought |
1 |
1 |
1 |
1 |
Total Buy Transactions |
1 |
1 |
1 |
1 |
Total Shares Sold |
0 |
0 |
6,815 |
22,740 |
Total Sell Value |
$0 |
$0 |
$1,357,080 |
$4,648,975 |
Total People Sold |
0 |
0 |
2 |
3 |
Total Sell Transactions |
0 |
0 |
5 |
17 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Ronaghi Mostafa |
SVP, Entrepreneurial Devlopmt |
|
2020-11-05 |
4 |
D |
$311.72 |
$365,024 |
D/D |
(1,171) |
85,162 |
|
- |
|
Tousi Susan H |
SVP Product Development |
|
2020-11-05 |
4 |
D |
$311.72 |
$349,438 |
D/D |
(1,121) |
43,847 |
|
- |
|
Mcginnis Karen K |
VP, Chief Accounting Officer |
|
2020-11-05 |
4 |
D |
$311.72 |
$51,746 |
D/D |
(166) |
2,184 |
|
- |
|
Samad Samer Abdul |
SVP and CFO |
|
2020-11-05 |
4 |
D |
$311.72 |
$171,758 |
D/D |
(551) |
3,328 |
|
- |
|
Goswami Joydeep |
SVP Corp Business Development |
|
2020-11-05 |
4 |
D |
$311.72 |
$45,199 |
D/D |
(145) |
2,732 |
|
- |
|
Van Oene Mark |
SVP Chief Commercial Officer |
|
2020-11-05 |
4 |
D |
$311.72 |
$334,476 |
D/D |
(1,073) |
16,575 |
|
- |
|
Flatley Jay T |
Director |
|
2020-11-03 |
4 |
AS |
$297.00 |
$892,010 |
D/D |
(3,000) |
199,933 |
|
41% |
|
Dadswell Charles |
SVP & General Counsel |
|
2020-11-02 |
4 |
AS |
$298.00 |
$36,058 |
D/D |
(121) |
6,036 |
|
44% |
|
Desouza Francis A |
President and CEO |
|
2020-11-02 |
4 |
AS |
$297.40 |
$900,852 |
D/D |
(3,000) |
65,840 |
|
44% |
|
Flatley Jay T |
Director |
|
2020-10-20 |
4 |
AS |
$320.95 |
$1,286,860 |
D/D |
(4,000) |
202,933 |
|
38% |
|
Tousi Susan H |
SVP Product Development |
|
2020-10-12 |
4 |
AS |
$350.00 |
$70,000 |
D/D |
(200) |
44,968 |
|
34% |
|
Flatley Jay T |
Director |
|
2020-10-07 |
4 |
AS |
$324.01 |
$324,010 |
D/D |
(1,000) |
206,933 |
|
50% |
|
Tousi Susan H |
SVP Product Development |
|
2020-10-07 |
4 |
AS |
$325.00 |
$32,500 |
D/D |
(100) |
45,168 |
|
50% |
|
Flatley Jay T |
Director |
|
2020-10-06 |
4 |
AS |
$317.79 |
$953,370 |
D/D |
(3,000) |
207,933 |
|
56% |
|
Reeves Kathryne Gambrell |
SVP, Chief Marketing Officer |
|
2020-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,187 |
1,187 |
|
- |
|
Goswami Joydeep |
SVP Corp Business Development |
|
2020-10-05 |
4 |
D |
$316.17 |
$36,360 |
D/D |
(115) |
2,877 |
|
- |
|
Dadswell Charles |
SVP & General Counsel |
|
2020-10-01 |
4 |
AS |
$312.82 |
$37,851 |
D/D |
(121) |
6,157 |
|
46% |
|
Desouza Francis A |
President and CEO |
|
2020-10-01 |
4 |
AS |
$306.99 |
$926,331 |
D/D |
(3,000) |
68,840 |
|
46% |
|
Flatley Jay T |
Director |
|
2020-09-15 |
4 |
AS |
$355.22 |
$1,420,880 |
D/D |
(4,000) |
210,933 |
|
23% |
|
Tousi Susan H |
SVP Product Development |
|
2020-09-09 |
4 |
AS |
$350.00 |
$70,000 |
D/D |
(200) |
45,268 |
|
17% |
|
Tousi Susan H |
SVP Product Development |
|
2020-09-08 |
4 |
AS |
$336.00 |
$33,600 |
D/D |
(100) |
45,468 |
|
18% |
|
Desouza Francis A |
President and CEO |
|
2020-09-01 |
4 |
AS |
$349.55 |
$1,056,964 |
D/D |
(3,000) |
71,840 |
|
4% |
|
Van Oene Mark |
SVP Chief Commercial Officer |
|
2020-09-01 |
4 |
AS |
$355.04 |
$221,953 |
D/D |
(625) |
17,648 |
|
4% |
|
Dadswell Charles |
SVP & General Counsel |
|
2020-09-01 |
4 |
AS |
$355.35 |
$599,475 |
D/D |
(1,687) |
6,278 |
|
4% |
|
Flatley Jay T |
Director |
|
2020-09-01 |
4 |
AS |
$355.35 |
$1,421,400 |
D/D |
(4,000) |
214,933 |
|
4% |
|
3455 Records found
|
|
Page 13 of 139 |
|
|